Home › Cases › High-Risk NSTEMI
NSTEMI
High-Risk NSTEMI
6 questions
Question 1 · Initial assessment
Correct answer: NSTEMI — ST depression and troponin rise without ST elevation
Why
NSTEMI: troponin rise above ULN + ischaemic symptoms, without ST elevation. ST depression confirms ischaemia but not STEMI territory.
Key point
NSTEMI = troponin rise + symptoms, no ST elevation. ST depression confirms ischaemia.
Question 2 · Risk stratification
Correct answer: High risk — discuss early angiography within 24 hours with cardiology
Why
GRACE >140 is the traditional high-risk category (>3% in-hospital mortality). ESC advises considering angiography within 24h. NICE advises considering angiography within 72h of first admission when predicted 6-month mortality >3%. Refractory ischaemia or haemodynamic instability: immediate angiography—do not wait for the routine window.
Key point
GRACE >140: discuss early angiography within 24h (ESC). Refractory ischaemia or instability: immediate angiography.
Question 3 · Dual antiplatelet therapy
Correct answer: Aspirin 300mg loading + ticagrelor 180mg loading (DAPT)
Why
DAPT: aspirin 300mg loading then 75mg daily + ticagrelor 180mg loading then 90mg BD. Ticagrelor superior to clopidogrel in ACS (PLATO trial). Check bleeding risk and contraindications, including previous intracranial haemorrhage. Prior ischaemic stroke alone is not a contraindication to the ACS course. With unknown anatomy and angiography planned within 24h, do not routinely preload a P2Y12 inhibitor; agree timing with cardiology.
Key point
If ticagrelor selected: aspirin 300mg + ticagrelor 180mg loading. For early NSTEMI angiography, agree P2Y12 timing with cardiology.
Question 4 · Anticoagulation
Correct answer: Fondaparinux 2.5mg SC daily (preferred) or LMWH if Fondaparinux unavailable
Why
Fondaparinux 2.5mg SC daily is preferred: lower bleeding risk than LMWH, equal anti-ischaemic efficacy. Continue until angiography.
Key point
Fondaparinux 2.5mg SC daily in NSTEMI — lower bleeding risk than LMWH.
Question 5 · Complications
Correct answer: Acute decompensated heart failure — NSTEMI complication
Why
Acute pulmonary oedema post-NSTEMI suggests ischaemic LV dysfunction. Call senior cardiology/critical care; give IV furosemide and oxygen for hypoxaemia, and expedite angiography. Consider CPAP/NIV for severe dyspnoea with acidaemia or inadequate response to treatment; monitor BP closely because positive pressure can worsen hypotension.
Key point
Acute HF post-NSTEMI: urgent cardiology, IV diuresis, oxygen for hypoxaemia and expedited angiography. CPAP/NIV if indicated, with close BP monitoring.
Question 6 · Secondary prevention
Correct answer: Aspirin + ticagrelor (12 months), high-intensity statin, ACE inhibitor, beta-blocker
Why
Post-PCI for ACS: DAPT for 12 months (aspirin + ticagrelor, unless bleeding risk requires a different plan), atorvastatin 80 mg, ACEi and a beta-blocker once stable. Check LV function: NICE advises considering beta-blockers for 12 months without reduced EF and continuing indefinitely with reduced EF. Long-term beta-blocker mortality benefit is not established when EF is preserved and there is no other indication.
Key point
Post-ACS: DAPT 12 months, statin, ACEi and beta-blocker once stable, unless contraindicated. Review LV function, bleeding risk and treatment duration.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.